Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up RareLink now aims to address this gap with its MyaLink…
Dr. med. Livius Penter, internist, and Dr. med. Jana Ihlow, pathologist, are fellows in the Clinician Scientist Program researching how allogeneic stem cell transplants and immunotherapeutic strategies can be used to treat acute myeloid leukaemia (AML). The Brigitte and Dr. Konstanze Wegener Foundation is now funding their joint project beginning…
With the support of SPARK-BIH and the BIH Biomedical Innovation Academy (BIA), the first cohorts in the project and personal funding programs of the National Strategy for Gene- and Cell-Based Therapies (GCT) have been selected. Within the project funding according to the SPARK method, 17 projects from 13 cities throughout Germany are being funded…
On the occasion of the European Month of Diversity, we are taking a stand for openness and inclusivity in science. For us, equal opportunities and diversity are more than just words- they are fundamental requirements for innovation and high- quality research.
In cooperation with the German Academic Exchange Service (DAAD), the Maison Heinrich Heine (MHH) and with the support of the German embassies, the exhibition ‘Berlin - Capital of Women Scientists’ travelled to Paris and Brussels.
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces, to support operations at the full-service BIH…
Researchers from the Berlin Institute of Health at Charité (BIH), the Center for Musculoskeletal Surgery at Charité – Universitätsmedizin Berlin, Jena University Hospital, ETH Zurich and the Max Planck Institute of Colloids and Interfaces have uncovered a novel mechanism that links the water-binding properties of the extracellular matrix (ECM) in…
At the beginning of May, the BIH Digital Health Accelerator welcomed the eighth project cohort with eleven new teams of innovators from clinical practice and research at Charité and BIH.
